Get started
Author

Pei-Hsuan Chen

Taming Pancreatic Cancer: Ardisia virens Kurz-Derived 4-Hydroxy-2-Methoxy-6-Tridecylphenyl Acetate as a Potent Tubulin Polymerization Inhibitor for Targeted Pancreatic Ductal Adenocarcinoma Therapy
2025 · Chia-Hung Yen, Chien-Ju Lin, et al. · International Journal of Medical Sciences · 1
PDF
Supplementary Info from Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker
2023 · Tzu-Fang Lou, Deepa Sethuraman, et al.
Supplementary Table S3 from Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker
2023 · Tzu-Fang Lou, Deepa Sethuraman, et al.
Supplementary Table S2 from Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker
2023 · Tzu-Fang Lou, Deepa Sethuraman, et al.
Supplementary Table S4 from Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker
2023 · Tzu-Fang Lou, Deepa Sethuraman, et al.
Supplementary Table S2 from Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker
2023 · Tzu-Fang Lou, Deepa Sethuraman, et al.
Data from Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker
2023 · Tzu-Fang Lou, Deepa Sethuraman, et al.
Supplementary Info from Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker
2023 · Tzu-Fang Lou, Deepa Sethuraman, et al.
Supplementary Figures S1-S11 from Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker
2023 · Tzu-Fang Lou, Deepa Sethuraman, et al.
Supplementary Table S3 from Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker
2023 · Tzu-Fang Lou, Deepa Sethuraman, et al.
Supplementary Table S1 from Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker
2023 · Tzu-Fang Lou, Deepa Sethuraman, et al.
Supplementary Table S4 from Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker
2023 · Tzu-Fang Lou, Deepa Sethuraman, et al.
Supplementary Table S1 from Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker
2023 · Tzu-Fang Lou, Deepa Sethuraman, et al.
Supplementary Figures S1-S11 from Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker
2023 · Tzu-Fang Lou, Deepa Sethuraman, et al.
Data from Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker
2023 · Tzu-Fang Lou, Deepa Sethuraman, et al.
Works count: 15
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type